Evidence map›Paper›PMID 24261833›Full record

ArticleJournal of the American Chemical Society2013

A 18F-labeled saxitoxin derivative for in vivo PET-MR imaging of voltage-gated sodium channel expression following nerve injury.

Aileen Hoehne, Deepak Behera, William H Parsons, Michelle L James, Bin Shen, Preeti Borgohain, Deepika Bodapati, Archana Prabhakar, Sanjiv S Gambhir, David C Yeomans and 3 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Saxiphilin is a broad-spectrum toxin sponge for C13-modified saxitoxins.bioRxiv : the preprint server for biology · 2026
    Article
  3. Toward Brain NaPharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Up-and-coming Radiotracers for Imaging Pain Generators.Seminars in musculoskeletal radiology · 2023
    Article
  6. Development and Validation of Nerve-Targeted Bacteriochlorin Sensors.Journal of the American Chemical Society · 2023
    Article
  7. Review
  8. Review
  9. Bone & joint research · 2021
    Article
  10. Article
  11. Taming unruly chloride channel inhibitors with rational design.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Aileen HoehneDepartment of Radiology, ‡Department of Chemistry, and §Department of Anesthesia, Stanford University , Stanford, California 94305, United States.
Deepak Behera
William H Parsons
Michelle L James
Bin Shen
Preeti Borgohain
Deepika Bodapati
Archana Prabhakar
Sanjiv S Gambhir
David C Yeomans
Sandip Biswal
Frederick T Chin
J Du Bois

Funding

Small Animal ImagingP50CA114747 · NCI · STANFORD UNIVERSITY · PI RAO, JIANGHONG · 2005 to 2014
$18.2M
Reaction Design for the Synthesis of Neuroactive AgentsR01NS045684 · NINDS · STANFORD UNIVERSITY · PI DU BOIS, JUSTIN · 2003 to 2011
$3.0M
NCI NIH HHS P50 CA114747NINDS NIH HHS R01 NS045684
6 · The paper itself

Abstract

Both chronic and neuropathic pain conditions are associated with increased expression of certain voltage-gated sodium ion channel (NaV) isoforms in peripheral sensory neurons. A method for noninvasive imaging of these channels could represent a powerful tool for investigating aberrant expression of NaV and its role in pain pathogenesis. Herein, we describe the synthesis and evaluation of a positron emission tomography (PET) radiotracer targeting NaVs, the design of which is based on the potent, NaV-selective inhibitor saxitoxin. Both autoradiography analysis of sciatic nerves excised from injured rats as well as whole animal PET-MR imaging demonstrate that a systemically administered [(18)F]-labeled saxitoxin derivative concentrates at the site of nerve injury, consistent with upregulated sodium channel expression following axotomy. This type of PET agent has potential use for serial monitoring of channel expression levels at injured nerves throughout wound healing and/or following drug treatment. Such information may be correlated with pain behavioral analyses to help shed light on the complex molecular processes that underlie pain sensation.

Indexed as

AnimalsFluorine RadioisotopesMagnetic Resonance ImagingNeuralgiaPositron-Emission TomographyRatsSaxitoxinSciatic NerveVoltage-Gated Sodium Channel BlockersVoltage-Gated Sodium ChannelsFluorine RadioisotopesSaxitoxinVoltage-Gated Sodium Channel BlockersVoltage-Gated Sodium Channels

Identifiers

PMID24261833
PMCPMC8757660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.